
Last updated: 2026-09-12 11:50:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Korsana Biosciences, Inc. (KRSA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $31,82, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $21,00 to $32,13. This page covers its latest market performance, valuation, price trends and company information.
-- | |
$25,22 | |
$32,13 | |
$21,00 | |
$24,56 | |
112,73K | |
58,48K | |
-- | |
$32,13 | |
$21,00 | |
-- | |
-- |
Korsana Biosciences, Inc. (KRSA) last closed at $24,56 as of 2026-09-11 23:31:00, unchanged from the previous close of $24,56.
During the latest regular trading session, KRSA traded between $21,00 and $32,13, with a volume of 112,73K shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, Korsana Biosciences, Inc. (KRSA) moved from $26,20 to $31,82, representing a gain of 21,43% ($5,62).
The stock traded between $21,00 and $32,13 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 58,48 thousand shares, -- versus the previous seven-day period, indicating -- trading activity.
Position in Range: 97,2%
KRSA is currently trading at $31,82, placing it 97,2% of the way from its 52-week low of $21,00 to its 52-week high of $32,13. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Korsana Biosciences Inc is a biopharmaceutical company developing therapeutics to treat neurodegenerative diseases beginning with Alzheimer's disease (AD. The company's flagship product candidate, KRSA-028, is an anti-amyloid beta antibody that combines the proprietary Therapeutic Targeting (THETA) platform with well-validated aspects from other anti-Ab products that have achieved regulatory approval or are in late-stage clinical trials.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Korsana Biosciences, Inc. (KRSA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.